-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Luye Pharmaceutical Group announced that its self-developed innovative preparation, Liss’ Mindo Day transdermal patch, has successfully passed the EU decentralized review process.
Alzheimer's disease is an irreversible neurodegenerative disease.
Alzheimer's disease is known as one of the most difficult treatment areas to break through.
Outside of the European market, Liss's Mingda day transdermal patch is about to start phase III clinical trials in Japan.
Note: The original text has been deleted